CD4 and cancer: Furthermore, we looked at the CD4 count at the time of cancer diagnosis, and whilst the CD4 count has increased at the time of diagnosis for NADCs over time, it has remained constant for ADCs, suggesting that early HIV diagnosis and provision of effective ART for individuals with low CD4 counts remains a priority.